[1]
“EXACERBATIONS OF THE USE OF SELENIUM-CONTAINING DRUGS IN PREGNANT WOMEN IN THE PREVENTION OF FETOPLACENTAR DEFICIENCY”, Web med., vol. 3, no. 2, pp. 261–264, Feb. 2025, Accessed: Oct. 03, 2025. [Online]. Available: https://webofjournals.com/index.php/5/article/view/3279